The quiet potential of supplements and fortified foods
What do companies like Vitamin Shoppe, Johnson & Johnson, DSM, Whole Foods, NBTY and even Pfizer have in common?
Archives for May 10, 2009
Hydroxycut recall prompts calls for DSHEA review
The recent recall of top-selling Hydroxycut weight loss products has prompted the – not unexpected – call for a review of regulations governing dietary supplements in the United States.
Wild Flavors seeks external stevia safety stamp
Wild Flavors has said it is aggressively working toward external safety assessment of its stevia extracts as it becomes the latest company to announce the launch of a stevia flavor solutions range.
Grand plans for vitamins
Vitamin Angels – often referred to as the humanitarian arm of the natural products industry – provides the framework for companies to donate nutritional supplements or fortified foods to children who urgently need them.
Dispatches from Vitafoods
Danone plays waiting game on health claims
After taking part in a Pharmanager seminar at Vitafoods in Geneva, Dr Jean-Michel Antoine, a 30-year research and development veteran at Danone, tells Shane Starling why the French dairy firm has pulled three article 13.5 probiotic yoghurt claims from...
Asian brands show western functional potential
While analyst suggests Asian food and drink companies are behind their Western counterparts in driving product innovation, manufacturers in the region may still be able to lead in way in meeting western demand for certain functional goods.
Mediterranean diet may lower blood pressure: Study
Following a Mediterranean-style diet, rich in olive oil and fruit and vegetables, may improve vascular health and reduce the risk of hypertension, says a new study.
Market expected to rebound from Hydroxycut blow
The recent recall of the top-selling weight loss supplement brand Hydroxycut will further erode consumer confidence in the category, but the market will ultimately rebound, says an ingredients player.
Dispatches from Vitafoods
The true cost of health claims and why patience is a virtue
Are health claims dossiers really that expensive, and has the ‘wait and see’ approach to submitting dossiers won? Stephen Daniells speaks to Joerg Gruenwald, PhD, President of Analyze & Realize, about how much it costs to compile a dossier, and why it’s...